Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Corcept Therapeutics Inc CORT

Healthcare
Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has... see more

Recent & Breaking News (NDAQ:CORT)

Mid-Morning Market Update: Markets Open Higher; Wal-Mart Reports $20B Buyback Plan

Benzinga.com  October 10, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  August 2, 2017

Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update

GlobeNewswire August 1, 2017

How These Biotech Stocks are Performing? -- Intrexon, 22nd Century, Corcept Therapeutics, and Achaogen

PR Newswire July 26, 2017

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

GlobeNewswire July 25, 2017

Research Reports Initiation on Biotech Stocks -- Corcept Therapeutics, Curis, OvaScience, and Vanda Pharma

PR Newswire May 30, 2017

Corcept Therapeutics Announces Presentations on Mifepristone for the Treatment of Patients with Hypercortisolism at the American Association of Clinical Endocrinologists 26th Annual Congress

Marketwired May 4, 2017

Corcept Therapeutics Announces First Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update

Marketwired May 1, 2017

Investor Network: Corcept Therapeutics Incorporated. to Host Earnings Call

Accesswire May 1, 2017

Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call

Marketwired April 24, 2017

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance

Marketwired March 6, 2017

Ladenburg On Biotech: Starts Achillion, Alnylam, Corcept, Trevana At Buy

Benzinga.com  February 2, 2017

Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update; Provides 2017 Revenue Guidance

Marketwired January 30, 2017

Research Reports Coverage on Biotech Stocks -- PharmAthene, Corcept Therapeutics, Navidea Biopharma, and Inotek Pharma

PR Newswire January 25, 2017

Corcept Therapeutics to Announce Preliminary 2016 Financial Results, Provide 2017 Revenue Guidance and Corporate Update, and Host Conference Call

Marketwired January 23, 2017

Research Reports Coverage on Biotech Stocks -- Idera Pharma, bluebird bio, Corcept Therapeutics, and PhaseRx

PR Newswire December 16, 2016

Corcept Therapeutics Announces Encouraging Results of Phase 1/2 Trial of Mifepristone Plus Eribulin in Triple-Negative Breast Cancer

Marketwired December 10, 2016

Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update

Marketwired November 1, 2016

Corcept Therapeutics to Announce Third Quarter 2016 Financial Results and Corporate Update and Host Conference Call

Marketwired October 26, 2016

Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update

Marketwired August 2, 2016